1255.1000 1.40 (0.11%)
NSE Sep 03, 2025 10:32 AM
Volume: 203.4K
 

ICICI Securities Limited
Q3FY19 results were higher than I-direct estimates on profitability front while revenues were lower mainly due to lower US sales. Revenues were muted at | 3864.6 crore (I-direct estimate: | 4015 crore). Growth of 10% in domestic market to | 674.1 crore (I-direct estimate: | 674 crore) and 25.0% YoY growth in Russia & CIS to | 550 crore (I-direct estimate: | 550 crore) were largely offset by 7.7% fall in US sales to | 1483.2 crore (I-direct estimate: | 1600 crore) EBITDA margins remained at 20.8% YoY but came in 212 bps higher...
Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended